Precision Medicine for Advanced Pancreas Cancer: The Individualized Molecular Pancreatic Cancer Therapy (IMPaCT) Trial.
about
Pancreatic Cancer from Molecular Pathways to Treatment OpinionPancreatic cancer from bench to bedside: molecular pathways and treatment optionsState of the art biological therapies in pancreatic cancerIs it time to split strategies to treat homologous recombinant deficiency in pancreas cancer?Clinical applications of liquid biopsies in gastrointestinal oncologyFOLFIRINOX and translational studies: Towards personalized therapy in pancreatic cancerDeciphering the link between PI3K and PAK: An opportunity to target key pathways in pancreatic cancer?Single-cell sequencing and tumorigenesis: improved understanding of tumor evolution and metastasis.Evolving landscape of tumor molecular profiling for personalized cancer therapy: a comprehensive review.Whole Genome Sequencing of Newly Established Pancreatic Cancer Lines Identifies Novel Somatic Mutation (c.2587G>A) in Axon Guidance Receptor Plexin A1 as Enhancer of Proliferation and Invasion.Clinical utility of circulating tumor DNA for molecular assessment in pancreatic cancer.Minimally invasive genomic and transcriptomic profiling of visceral cancers by next-generation sequencing of circulating exosomes.Immunotherapy in glioblastoma: emerging options in precision medicinePrecision medicine for advanced prostate cancer.Genetic Diversity of Pancreatic Ductal Adenocarcinoma and Opportunities for Precision MedicineImpact of genomic profiling on the treatment and outcomes of patients with advanced gastrointestinal malignancies.From Clinical Standards to Translating Next-Generation Sequencing Research into Patient Care Improvement for Hepatobiliary and Pancreatic CancersMolecular Subtyping of Pancreatic Cancer: Translating Genomics and Transcriptomics into the Clinic.Patient-centric trials for therapeutic development in precision oncology.Bioinformatory-assisted analysis of next-generation sequencing data for precision medicine in pancreatic cancer.Genomic instability in pancreatic adenocarcinoma: a new step towards precision medicine and novel therapeutic approaches.Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance.Pancreatic cancer biology and genetics from an evolutionary perspective.Leveraging Mechanisms Governing Pancreatic Tumorigenesis To Reduce Pancreatic Cancer Mortality.The Role of BRCA2 Mutation Status as Diagnostic, Predictive, and Prognosis Biomarker for Pancreatic Cancer.Endoscopic ultrasonography-guided biopsy using a Franseen needle design: Initial assessment.Current companion diagnostics in advanced colorectal cancer; getting a bigger and better piece of the piePancreatic Ductal Adenocarcinoma: Current and Evolving Therapies.Personalized and precision medicine: integrating genomics into treatment decisions in gastrointestinal malignancies.Endoscopic ultrasound-guided fine-needle aspirate-derived preclinical pancreatic cancer models reveal panitumumab sensitivity in KRAS wild-type tumors.Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer - Early Results from the COMPASS Trial.Future Clinical Trials: Genetically Driven Trials.Extracellular Influences: Molecular Subclasses and the Microenvironment in Pancreatic Cancer.Targeted tumor detection: guidelines for developing biotinylated diagnostics.Reviewing the Utility of EUS FNA to Advance Precision Medicine in Pancreatic Cancer.Patient-derived organoid models help define personalized management of gastrointestinal cancer.Precision oncology in the age of integrative genomics.Next generation sequencing of pancreatic ductal adenocarcinoma: right or wrong?An animal experimental study to assess the core tissue acquisition ability of endoscopic ultrasound-guided histology needles.Targeted therapies in the management of locally advanced and metastatic pancreatic cancer: a systematic review.
P2860
Q26743482-CD286DD8-47E4-44BE-83B9-4D6A6D02B2CDQ26747524-FDF4EAE6-16AC-45A8-B8B4-A6D6F79478E9Q26769941-14891B2A-B8DB-4442-BD86-3547D2E55D17Q28073673-C67BC99F-96CF-47A3-8640-322085033549Q28073730-2B9EC31E-F568-4A6B-B032-938A66077FE8Q28075540-63C216DD-39ED-4CE2-80AE-F74C4A3EC94CQ28079848-66775BC1-9A99-4091-B051-DF09DD446D11Q33559128-CCC710B8-B35C-4ED8-B5CC-D7B7E6434E02Q34529131-124196AC-4E2A-4596-8BA9-E136E7BEE31CQ35952075-498174F9-B654-4491-836A-BFB977442B60Q36376138-2260CE57-04F8-4EE8-A055-89F0AEB27BBDQ36716660-739569AE-8885-4BCF-A028-78EBE3E51916Q37050960-0DA2A82A-7680-4219-8243-2ED4C88D2FA0Q37114034-91BCB0D2-7469-4EC4-A338-4BDED288F4C4Q37230991-FC6DB8AE-5047-4151-A813-CB0B95A42BCDQ37609448-B896CC63-4C71-4EEF-9D17-7E11485ABAA1Q37631655-470D035D-B1E3-4F35-80F8-675618507576Q37726365-FA66C279-96BF-49D3-A47A-B1B171138019Q38607709-D4C4108C-F0C4-4321-8DFF-B282410F065EQ38694488-CF5C8360-1256-41B9-8694-4CF521FA7103Q38735426-2C218EA6-006A-436A-9A10-14877B2524C2Q38748208-3BC983CA-3491-49BC-9B7B-EFA5F3FF7105Q38904824-02320435-5B83-44CF-8418-2741AF5280C1Q38909404-8005501E-7AE0-4F3B-B7C0-A2803C8D0CBAQ39080898-97B18C43-47AF-4F57-8F42-41C9937FF4DAQ39160038-1453BFD6-B9F3-42B0-BD18-2220627E6E23Q39172118-E4C38372-40BE-4FFD-A990-0199E3825BA7Q39390859-243CCECB-ECCE-4C99-B79B-39A79EC3E637Q39453553-3E01E9A0-9F75-4474-BA9A-50D0C8E3A9F3Q40332952-C66F32B3-0B01-4CD9-BC17-5F05047064F6Q47232401-BFE880DD-5ABB-415C-AE61-5104840A0D5EQ47942762-E065F6C1-422D-4525-B685-7016F4D84499Q48141138-9E6D92E8-10D9-4130-823C-3F03A130F3A7Q48295925-A95CE37D-CC10-4C90-8463-752CC0617CF8Q49576059-FA21794F-44D1-43B0-BAA1-381AD8C52AECQ50010294-AB77763A-A3BC-4937-8678-A600171D4D6EQ50105699-463A25F5-5AD3-4B69-8624-0BE788459657Q54277914-57FB166C-1F92-4FE0-8892-5CAFD06ED6F1Q54781121-9A31E456-744F-47F6-A92A-9BCBCB40CD40Q54974100-768E75FF-7D7B-41E8-9D18-0DE99504C633
P2860
Precision Medicine for Advanced Pancreas Cancer: The Individualized Molecular Pancreatic Cancer Therapy (IMPaCT) Trial.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Precision Medicine for Advance ...... Cancer Therapy (IMPaCT) Trial.
@en
type
label
Precision Medicine for Advance ...... Cancer Therapy (IMPaCT) Trial.
@en
prefLabel
Precision Medicine for Advance ...... Cancer Therapy (IMPaCT) Trial.
@en
P2093
P50
P1476
Precision Medicine for Advance ...... Cancer Therapy (IMPaCT) Trial.
@en
P2093
Adnan M Nagrial
Adrienne Morey
Amber L Johns
Angela Chou
Anthony J Gill
Australian Pancreatic Cancer Genome Initiative (APGI)
Belinda Brown
Clare Watson
Individualized Molecular Pancr ...... ntestinal Trials Group (AGITG)
Jaswinder S Samra
P304
P356
10.1158/1078-0432.CCR-15-0426
P407
P50
P577
2015-05-01T00:00:00Z